Period29 Sep 2023

Media coverage

1

Media coverage

  • TitleThe FDA is requesting additional data regarding Neffy, the first needle-free antidote designed to treat severe allergic reactions
    Media name/outletIndian Pharma Industry : Policies
    Country/TerritoryIndia
    Date29/09/23
    PersonsScott Sicherer